MBX (MBX) Stock Price & Analysis
MBX (MBX) rose 0.00% to USD 62 as of July 25, 2026 at 04:13 UTC, according to Nexqual real-time market data.
MBX last closed at USD 62; the session ranged USD 60.85–66.66 on volume of 488,398 shares. Market capitalization is —, with a 52-week range of USD 9.63–66.66 (NMS). Source: Nexqual, July 25, 2026 at 04:13 UTC.
Key Statistics (as of July 25, 2026 at 04:13 UTC)
| Price | USD 62 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 62 |
| Open | USD 62 |
| Day Range | USD 60.85 – 66.66 |
| 52-Week Range | USD 9.63 – 66.66 |
| Volume | 488,398 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (MBX)
Nexqual's technical model rates MBX "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 04:13 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 63.74 (neutral) |
| vs SMA50 | Above (USD 44.86) |
| MACD | 4.65 (positive) |
From MBX's Latest SEC 10-K Filing (filed 2026-03-12)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RAPP | Rapport Therapeutics, Inc. | USD 40.68 | ▼ 1.57% |
| BCAX | Bicara Therapeutics Inc. | USD 27.02 | ▼ 3.36% |
| ZBIO | Zenas BioPharma, Inc. | USD 30.39 | ▼ 3.49% |
| ALMS | Alumis Inc. | USD 28 | ▼ 2.81% |
| MLYS | Mineralys Therapeutics, Inc. | USD 26.71 | ▼ 1.11% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:13 UTC. This page is informational and not investment advice.